AURAD GMBH – Trademark Portfolio
Entity Type: 16
AURAD GMBH holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 6 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include LUCID, VIVACAM, VIVANET, VIVASCAN, and VIVABLOCK. The owner is based in MUNICH.
STAHLGRUBERRING 5
MUNICH 81829 , DE
Showing of trademarks Trademarks
Trademark Classifications
AURAD GMBH's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AURAD GMBH have?
AURAD GMBH has 11 U.S. trademarks filed with the USPTO. Of these, 8 registered, 2 abandoned, 1 cancelled.
What trademark classes does AURAD GMBH file in?
AURAD GMBH files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 38 (Telecommunications). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are AURAD GMBH's most well-known trademarks?
AURAD GMBH's registered trademark portfolio includes well-known marks such as LUCID, VIVACAM, VIVANET, VIVASCAN, and VIVABLOCK. These are among 8 currently registered trademarks in the portfolio.
What is AURAD GMBH's trademark registration success rate?
AURAD GMBH has a 73% trademark registration rate, with 8 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.